Wenjing Yang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related gene regulation 2
- Wnt/β-catenin signaling in development and cancer 2
- Ubiquitin and proteasome pathways 1
- S100 Proteins and Annexins 1
-
- NF-κB Signaling Pathways 2
- Co-authors
- Xin Zhang (1 shared paper)Xuehai Zhang (1 shared paper)Junpeng Zhang (1 shared paper)Shuang Sun (1 shared paper)Wei Zhou (1 shared paper)Zheng Jiang (1 shared paper)Yufeng Cheng (3 shared papers)Pengxiang Chen (3 shared papers)
- Journals
- OncoTargets and Therapy (2 papers)Cancer Letters (1 paper)Journal of Clinical Oncology (1 paper)BioMed Research International (1 paper)DNA and Cell Biology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wenjing Yang
16 papers receiving 428 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 104
- Otorhinolaryngology 16
- Oncology 85
- Molecular Biology 170
- Genetics 22
Countries citing papers authored by Wenjing Yang
This map shows the geographic impact of Wenjing Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjing Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjing Yang more than expected).
Fields of papers citing papers by Wenjing Yang
This network shows the impact of papers produced by Wenjing Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjing Yang. The network helps show where Wenjing Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenjing Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 100 | |
| 2 | 2024 | 43 | |
| 3 | 2017 | 39 | |
| 4 | 2020 | 34 | |
| 5 | 2016 | 29 | |
| 6 | 2019 | 26 | |
| 7 | 2017 | 25 | |
| 8 | 2009 | 24 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 22 | |
| 11 | 2022 | 19 | |
| 12 | 2017 | 19 | |
| 13 | 2014 | 11 | |
| 14 | 2018 | 9 | |
| 15 | 2018 | 7 | |
| 16 | 2021 | 2 | |
| 17 | 2017 | 0 |
About Wenjing Yang
Wenjing Yang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 17 papers that have together received 431 indexed citations. Recurring topics across this work include Cancer-related gene regulation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), NF-κB Signaling Pathways (2 papers), Head and Neck Cancer Studies (1 paper), Ferroptosis and cancer prognosis (1 paper), Ubiquitin and proteasome pathways (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Cancer Research (104 citations), Otorhinolaryngology (16 citations), Oncology (85 citations), Molecular Biology (170 citations) and Genetics (22 citations). Wenjing Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xin Zhang, Xuehai Zhang, Junpeng Zhang, Shuang Sun, Wei Zhou, Zheng Jiang, Yufeng Cheng, Pengxiang Chen, Jianbo Wang and Yan Qu. Their work appears in journals such as OncoTargets and Therapy, Cancer Letters, Journal of Clinical Oncology, BioMed Research International and DNA and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.